PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

End-of-day quote SPOTLIGHT STOCK MARKET AB 2026-09-30			5-day change	1st Jan Change
0.3150 ^SEK	+1.94%		-.--%	+44.50%

10-16	Pexa has installed another system in Germany	FW
09-29	Pexa saw strong interest at the ERS lung congress	FW

Market Cap	27.06M 2.73M 2.43M 2.25M 2.05M 3.87M 259M 3.93M 10.61M 135M 10.26M 10.04M 431M	P/E 2023	-2.18x	P/E 2024	-1.13x
Enterprise Value	21.47M 2.17M 1.93M 1.79M 1.62M 3.07M 206M 3.12M 8.42M 107M 8.14M 7.96M 342M	EV / Sales 2023	3.92x	EV / Sales 2024	8.49x
Free-Float	-	Yield 2023 *	-	Yield 2024	-

Markets		Quality
SPOTLIGHT STOCK MARKET AB	PEXA B	End-of-day quote
Deutsche Boerse AG	FA0	Delayed

10-16	Pexa has installed another system in Germany	FW
09-29	Pexa saw strong interest at the ERS lung congress	FW
09-03	Pexa technology featured in three research presentations at pulmonary congress	FW
08-28	Pexa reports modest performance shifts, CEO: new capital provides substantially greater flexibility	FW
08-28	PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Pexa's directed share issue registered after positive decision from ISP	FW
08-19	Pexa technology draws attention after silicosis study in Australia	FW
07-28	Pexa's rights issue was oversubscribed	FW
07-13	Pexa - Interview with CEO Tomas Gustafsson	FW
07-10	Pexa raises SEK10m in a directed share issue, Anders Hallberg becomes a major shareholder	FW
07-01	Pexa raises nearly 10 million kronor in fully guaranteed rights issue	FW
06-23	Pexa signs a SEK 7.5m contract with a global pharmaceutical company	FW
06-10	Pexa secures order from the US	FW

PExA AB Stock

Stocks

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

Valuation: PExA AB

Chart: PExA AB

Latest news: PExA AB

Analysts' recommendations: PExA AB

Press Releases: PExA AB

Quotes and Performance

Price Extremes

Managers and Directors: PExA AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

11-07	Pexa - Q3 Presentation 2025	FW
11-07	Pexa Reports Minor Earnings Changes as Company Advances Toward Diagnostic Applications	FW

09-03	PExA : at the world’s largest respiratory congress – three accepted abstracts featuring PExA to be presented	PU
06-23	PExA : signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million	PU
06-10	PExA : U.S. government agency customer orders upgrade of existing PExA system	PU
06-02	PExA : New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases	PU
05-13	PExA : partner in Dutch precision medicine project within COPD and interstitial lung diseases	PU

1 day	+1.94%
1 month	-4.26%
3 months	-43.75%
6 months	+34.62%
Current year	+44.50%

1 month	0.3	0.35
Current year	0.18	0.83
1 year	0.14	0.83
3 years	0.14	0.83
5 years	0.14	1.94
10 years	0.14	9.5

Manager	Title	Age	Since
Bengt Tomas Jan Gustafsson CEO	Chief Executive Officer	55	-
Jörgen Östling CTO	Chief Tech/Sci/R&D Officer	-	2017-12-31
Svante Höjer CTO	Chief Tech/Sci/R&D Officer	65	2014-12-31

Director	Title	Age	Since
Anna-Carin Olin BRD	Director/Board Member	66	2009-12-31
Claes Frederik Holmberg CHM	Chairman	72	2014-01-30
Björn Lennart Dahlöf BRD	Director/Board Member	73	2020-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PEXA AB	+1.94%	-.--%	+82.08%	-38.72%	3.92M
THERMO FISHER SCIENTIFIC, INC.	-0.93%	+4.86%	+28.54%	+41.24%	258B
DANAHER CORPORATION	-1.06%	+4.20%	+8.59%	+8.83%	163B
INTUITIVE SURGICAL, INC.	-0.27%	+0.65%	-1.82%	+55.64%	151B
BOSTON SCIENTIFIC CORPORATION	+0.57%	+3.88%	-54.60%	-11.40%	63.97B
EDWARDS LIFESCIENCES CORPORATION	-1.70%	+1.63%	+19.20%	+21.51%	50.78B
SIEMENS HEALTHINEERS AG	+1.47%	+5.90%	-12.94%	-13.05%	50.94B
AGILENT TECHNOLOGIES, INC.	-1.47%	+1.42%	+22.59%	+55.13%	49.49B
VEEVA SYSTEMS INC.	-0.85%	+4.81%	+6.02%	+46.42%	50.68B
WATERS CORPORATION	-1.62%	+0.73%	+30.48%	+71.24%	43.64B
Average	-0.39%	+3.78%	+12.81%	+23.69%	88.09B
Weighted average by Cap.	-0.70%	+4.83%	+9.14%	+32.19%

	2023	2024
Net sales	2.02M 203K 181K 168K 153K 288K 19.31M 292K 790K 10.08M 764K 747K 32.13M	720K 72.66K 64.59K 59.87K 54.47K 103K 6.9M 104K 282K 3.6M 273K 267K 11.47M
Net income	-8.04M -812K -722K -669K -609K -1.15M -77.08M -1.17M -3.15M -40.23M -3.05M -2.98M -128M	-10.16M -1.03M -912K -845K -769K -1.45M -97.39M -1.47M -3.98M -50.82M -3.85M -3.77M -162M
Net Debt	-9.6M -969K -862K -799K -727K -1.37M -92M -1.39M -3.76M -48.01M -3.64M -3.56M -153M	-5.59M -565K -502K -465K -423K -799K -53.6M -812K -2.19M -27.97M -2.12M -2.07M -89.17M